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Elastic fibers provide tissues with elasticity which is critical to the function of arteries, lungs, skin, and other
dynamic organs. Loss of elasticity is a major contributing factor in aging and diseases. However, the mechanism of
elastic fiber development and assembly is poorly understood. Here, we show that lack of fibulin-4, an extracellular
matrix molecule, abolishes elastogenesis. fibulin-4/ mice generated by gene targeting exhibited severe lung and
vascular defects including emphysema, artery tortuosity, irregularity, aneurysm, rupture, and resulting hemor-
rhages. All the homozygous mice died perinatally. The earliest abnormality noted was a uniformly narrowing of the
descending aorta in fibulin-4/ embryos at embryonic day 12.5 (E12.5). Aorta tortuosity and irregularity became
noticeable at E15.5. Histological analysis demonstrated that fibulin-4/mice do not develop intact elastic fibers but
contain irregular elastin aggregates. Electron microscopy revealed that the elastin aggregates are highly unusual in
that they contain evenly distributed rod-like filaments, in contrast to the amorphous appearance of normal elastic
fibers. Desmosine analysis indicated that elastin cross-links in fibulin-4/ tissues were largely diminished. How-
ever, expression of tropoelastin or lysyl oxidase mRNA was unaffected in fibulin-4/ mice. In addition, fibulin-4
strongly interacts with tropoelastin and colocalizes with elastic fibers in culture. These results demonstrate that
fibulin-4 plays an irreplaceable role in elastogenesis.
Elastic fibers with morphologically distinct architectures are
present in the extracellular matrix (ECM) to accommodate
elastic requirements and mechanical stresses imposed on dif-
ferent tissues. They are particularly abundant in elastic tissues
such as large blood vessels, lung, and skin. Loss of elasticity is
a major contributing factor in aging and a myriad of patholog-
ical conditions including emphysema, artery diseases, and cutis
laxa (39, 41, 44). Elastic fibers undergo irreversible structural
and compositional changes with age and in some pathological
conditions (41). Regardless of morphology, all elastic fibers
consist of cross-linked elastin, fibrillin-rich microfibrils, and
several associated molecules (23, 37, 38, 46). Elastin endows
the fiber with the characteristic property of elastic recoil. It is
chemically inert, extremely hydrophobic, and insoluble under
most conditions. Monomeric elastin, called tropoelastin, is se-
creted from the cell as a soluble protein. Isolated and purified
tropoelastin has been shown to exhibit a great tendency to
aggregate (coacervation) in physiological solution and at tem-
peratures in the physiological range, giving rise to supramo-
lecular structures very similar to those found in natural elastic
fibers (4, 5, 11). This self-aggregation property of tropoelastin
is thought to contribute to elastic fiber assembly in vivo. How-
ever, self-aggregation alone is insufficient to explain the effi-
ciency of the assembly process and the variable form of elastic
fibers in different tissues.
The formation of elastic fibers has been proposed to require
the deposition of tropoelastin on a preexisting scaffold, cross-
linking of tropoelastin monomers by lysyl oxidase (LOX) fam-
ily enzymes, and organization of the resulting insoluble elastin
matrix into mature fibers (37). Fibrillin-rich microfibrils are
thought to provide the scaffold for the deposition of elastin. Un-
expectedly, normal elastic fiber assembly was found to occur in
fibrillin-1 or fibrillin-2 mutant mice (2, 9, 42, 43). Therefore, the
molecular mechanism of elastic fiber assembly remains elusive.
A significant insight into elastogenesis comes from two re-
cent studies of fibulin-5/ mice. These mice exhibit disrupted
and disorganized elastic fibers throughout the body, indicating
that fibulin-5 (also known as DANCE or EVEC) plays an
important role in elastic fiber formation (40, 56). fibulin-5/
mice grow to adulthood without lethality but have loose skin,
vascular abnormalities, and emphysematous lungs. Fibulin-5
has an RGD motif and interacts with cell surface integrins and
elastin. Thus, it has been proposed to promote elastic fiber
formation by linking elastic fibers to cells (40, 56).
Fibulin-5 belongs to the fibulin family of six known ECM
proteins that share tandem arrays of calcium-binding epider-
mal growth factor domains and a characteristic carboxyl-ter-
minal fibulin domain (1, 10, 15, 52). Although little is known
about the functions of fibulins, mutations of individual mem-
bers have been associated with several diseases. A single mu-
tation of an arginine to trypotophan in fibulin-3 (also known as
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EFEMP1, S1-5, or FBNL) causes an inherited macular degen-
erative disease termed malattia leventinese or Doyne honey-
comb retinal dystrophy (51). Missense variations in other fibu-
lins have been detected in patients with age-related macular
degeneration (47, 50), the most common cause of incurable
blindness (6). Mutations in fibulin-5 have also been found in
some cutis laxa patients (29, 32). So far, fibulin-5 is the only
fibulin reported to be necessary for elastogenesis, whereas
fibulin-1-null mice are reported to die perinatally as a result of
hemorrhages, due to defects associated with capillary endothe-
lial cells (25). Knockout mice for other fibulins have not been
reported. Among the fibulins, fibulin-3, fibulin-4 (also known
as EFEMP2, MBP1, H411, or UPH1), and fibulin-5 share
highest homology with each other. These three fibulins are the
smallest members of the family, share 50% amino acid iden-
tity, and are nearly identical in their structural organization (1,
10, 15, 52). Despite this homology, fibulin-5 deficiency is not
compensated for by fibulin-3 or -4, suggesting that fibulin-3, -4,
and -5 are not functionally redundant.
The function of fibulin-4 is poorly understood. Several stud-
ies have consistently found that fibulin-4 promotes cell growth,
exhibits oncogenic properties, and is upregulated in tumor
tissues (14, 16, 19). fibulin-4 mRNA has been shown to be
widely expressed in various tissues throughout the body (14, 16,
18). High protein levels are present in blood vessel walls (18).
During development, fibulin-4 mRNA is expressed in mouse
embryos as early as embryonic day 7 (E7) (14). In this study, we
investigated the biological role of fibulin-4 through targeted
gene inactivation in mice. Remarkably, mice lacking fibulin-4
do not form elastic fibers, with resulting severe vascular and
lung defects; they die perinatally. These results demonstrate
that fibulin-4 plays an irreplaceable role in elastic fiber forma-
tion.
MATERIALS AND METHODS
fibulin-4/ mouse generation, Southern blot analysis, and RT-PCR. The
targeting vector was constructed using 2.5-kb (5) and 3-kb (3) mouse fibulin-4
genomic DNA fragments as homology arms. The two arms flanked a promoter-
less lacZ and a neomycin-resistant gene cassette (lacZ-neo). Homologous recom-
bination in mouse embryonic stem cells resulted in the insertion of the lacZ-neo
cassette into exon 4 of the mouse fibulin-4 locus. Germ line-transmitting chimeric
mice generated from the targeted embryonic stem cells were bred with C57BL/6
mice to produce F1 fibulin-4/ mice (Deltagen). Intercrossing of heterozygous
F1 mice generated F2 fibulin-4/ mice. Southern blot analysis was performed for
identification of homologous recombinants. Genomic DNA was extracted using
a DNA purification kit (Gentra) from mouse tail biopsy samples, digested with
KpnI, separated on a 0.5% SeaKem Gold agarose (Cambrex) gel, and trans-
ferred to a Hybond-N nylon membrane (Amersham) by capillary blotting. The
membrane was hybridized with a 5 or 3 external probe that is outside of the
homologous arm regions. The probes were labeled with 32P through random
priming using the Megaprime DNA Labeling system (Amersham). The labeled
probes were purified using ProbeQuant G-50 Micro Columns (Amersham).
Hybridization was performed using the MiracleHyb hybridization solution
(Stratagene) according to the manufacturer’s instructions. Reverse transcription-
PCR (RT-PCR) was performed as described previously (33) to confirm the
absence of fibulin-4 expression in homozygous mice. Total RNA was isolated
from wild-type, fibulin-4/, and fibulin-4/ mice at postnatal day 1 (P1).
Either a 5 or 3 primer set corresponding to mouse fibulin-4 cDNA sequence
was used in the PCRs. The 5 primer set (5-GGCCAGATCTATGCTCCCTTT
TGCCTCCTG-3 and 5-ACATCCACACAGCTCTCCTG-3) generates a
381-bp fragment, and the 3 primer set (5-TGTCGAGAGCAGCCTTCA
TC-3 and 5-GGCCGTCGACTCAGAAGGTATAGGCTCCCAC-3) gen-
erates a 357-bp fragment. fibulin-3 primers were used in the positive control.
Morphological and histological analyses. Timed pregnant mice were sacrificed
by CO2 asphyxiation for collection of embryos at E9.5 to E18.5. P1 pups were
sacrificed by cervical dislocation. Sacrificed embryos or P1 mice were immobi-
lized on agarose plates on their back. The ventral side of the embryos was gently
dissected away to expose the aorta and other large arteries. Blood vessels were
photographed with a dissecting microscope equipped with a charge-coupled
device camera.
For histology, whole embryos and tissues dissected from newborn pups were
fixed in Bouin’s fixative or 4% paraformaldehyde in 0.1 M phosphate buffer (pH
7.2), dehydrated, and embedded in paraffin. Ten-micrometer sections were
stained with hematoxylin and eosin or for elastin using elastin van Gieson stain
(Sigma).
Transmission electron microscopy. Dissected tissues were fixed overnight in
3% glutaraldehyde in 0.144 M cacodylate buffer, pH 7.2. One-micrometer sec-
tions of plastic-embedded samples were cut and stained with methylene blue to
examine the integrity of the tissue. Thin sections were cut on a Reichert Ultracut
microtome, counterstained with uranyl acetate, and examined and photographed
with a Philips CM-12S electron microscope.
Tissue desmosine assay. Tissue samples from P1 mice were collected from the
thoracic aorta and lung. The tissues were hydrolyzed in 6 N HCl at 100°C for
24 h, evaporated to dryness, and redissolved in water. Desmosine was quantified
by radioimmunoassay as previously described (49), and hydroxyproline was de-
termined by amino acid analysis.
Northern blot analysis. Eight micrograms of total RNA isolated from various
tissues of wild-type, fibulin-4/, and fibulin-4/ mice at P1 was separated on a
1% formaldehyde-agarose gel and transferred to a Hybond-XL nylon membrane
(Amersham). Prehybridization was performed by incubating the membrane for
4 h at 65°C in the hybridization buffer without the probe. The membrane was
hybridized with a 32P-labeled probe using the Megaprime DNA Labeling system
(Amersham). The fibulin-4 probe is a 357-bp mouse fibulin-4 cDNA fragment
amplified by RT-PCR, the tropoelastin probe is a 3.6-kb mouse tropoelastin
cDNA fragment containing the entire coding sequence released by SalI/NotI
digestion from vector pCMV-SPORT6-mELN (Open Biosystems), and the LOX
probe is a 4-kb mouse Lox cDNA fragment released by SalI-NotI digestion from
vector pCMV-SPORT6-mLOX (Open Biosystems). After the fibulin-4 probe
was used, the same membranes were stripped by being boiled for 30 min in 0.1%
sodium dodecyl sulfate (SDS), washed, and hybridized with other probes. A
mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe was used as
a control. A 1.2-kb GAPDH fragment was generated by RT-PCR using the
primers 5-CCGCATCTTCTTGTGCAGTGCCA-3 and 5-CGAACTTTATTG
ATGGTATTCAAGAGA.
Production of MAbs against human fibulin-4. cDNA encoding human fibu-
lin-4 (OriGene Technologies) without signal peptide was cloned into vector
pGEX-4T-2 (Pharmacia) to generate fibulin-4 fused with glutathione S-trans-
ferase (GST). GST–fibulin-4 or GST was purified as described previously (36).
Four mice were immunized with GST–fibulin-4. Sera (polyclonal antibodies)
from all the mice were characterized with both GST fusion proteins and lysates
of transfected 293T cells expressing recombinant fibulin-4. Hybridomas were
derived from one of these mice. Several different clones producing monoclonal
antibodies (MAbs) against fibulin-4 were identified by enzyme-linked immu-
nosorbent assay. Clones 7B9 (immunoglobulin G2a [IgG2a]) and 11E2 (IgG2b)
are of high specificity and titer.
Transfection, immunoprecipitation, and immunoblotting. 293T cells were
transfected with a control plasmid, pCMV6-XL4-fb4 (human fibulin-4 cDNA),
pCMV6-XL6-heln (human tropoelastin cDNA obtained from Origene), or both
pCMV6-XL4-fb4 and pCMV6-XL6-heln with Lipofectamine (Invitrogen). At
48 h after transfection, cells were lysed. Immunoprecipitation and immunoblot-
ting using antibodies against fibulin-4 and human elastin (Elastin Products Com-
pany) were performed as previously described (34) with modifications. To avoid
the interference of the IgG heavy chain in interpreting results of immunoblotting
following immunoprecipitation by the same or similar antibodies, immunopre-
cipitation was performed with antibodies covalently coupled to protein A-Sepha-
rose. Anti-fibulin-4 MAb 7B9 or a rabbit anti-human tropoelastin polyclonal
antibody (Elastin Products Company) was cross-linked to protein A-Sepharose
CL-4B (Pharmacia) using dimethylpimelimidate (Sigma) as previously described
(35). For each immunoprecipitation, cell lysate containing 200 g of total protein
was diluted to 1 ml with lysis buffer containing 50 mM Tris (pH 8.0), 150 mM
NaCl, 10% glycerol, 0.5% NP-40, 0.5% Triton X-100, 1 mM phenylmethylsulfonyl
fluoride, and a 1:100 dilution of protease inhibitor mixture III (Calbiochem). A
total of 25 l of antibody-protein A beads was incubated with the cell lysate for
4 h at 4°C. The immunoprecipitates were washed and resuspended in 30 l of
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer; 10 l of
the suspension was loaded to each well, resolved by SDS-PAGE on a 10% gel,
and transferred onto a polyvinylidene difluoride membrane (Millipore). Anti-
fibulin-4 MAb 11E2 or the anti-human tropoelastin antibody was used in immu-
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noblotting. Alkaline phosphatase-conjugated anti-mouse IgG2b or anti-rabbit
IgG (Jackson ImmunoResearch Laboratories) was used as a secondary antibody.
Production of recombinant fibulin-4 and solid-phase binding assay. Plasmid
pEF6/V5 (Invitrogen) was modified to place a preprotrypsin signal sequence, a
FLAG tag, and a His6 tag to the N terminus of its inserted protein. Mouse
fibulin-4 cDNA without the signal sequence was subcloned to the modified
vector. 293T cells were transfected with the resulting vector with Lipofectamine
Plus (Invitrogen), according to the manufacturer’s protocol. Stably transfected
cells were selected with Blasticidin (Invitrogen). Recombinant fibulin-4 was
purified from the serum-free conditioned medium of stable lines with TALON
His-Tag Purification resins (Clontech) according to the manufacturer’s instruc-
tions. The purity of the protein was confirmed by Coomassie blue staining of a
SDS-PAGE gel, and the protein concentration was determined with Coomassie
Plus reagent (Pierce). Various concentrations of purified fibulin-4 in Tris-buff-
ered saline containing 2% skim milk with 2 mM CaCl2 or 5 mM EDTA were used
as ligands for a solid-phase binding assay. Recombinant bovine tropoelastin was
prepared as previously described (26). Solid-phase binding assays using purified
tropoelastin were performed as previously described (54) with the modification
of 2 mM CaCl2 or 10 mM EDTA added in the buffer. Anti-FLAG M2 antibody
(Sigma) (1:2,000) was used as a primary antibody; horseradish peroxidase-con-
jugated anti-mouse IgG antibody (Santa Cruz) (1:3,000) was used as a secondary
antibody. A color reaction assay was performed with the R&D Substrate Re-
agent Pack, followed by optic density measurement at 450 nm.
Cell culture and immunostaining. Normal human skin fibroblasts were cul-
tured in Dulbecco’s modified Eagle’s medium with 10% fetal bovine serum at a
density of 8  104 cells per 1 well of 24-well plate (day 0). On day 3, the medium
was changed to Dulbecco’s modified Eagle’s medium-F12 with 10% fetal bovine
serum and recombinant mouse fibulin-4 at a concentration of 5 g/ml. On day 12,
cells were fixed with 100% methanol and stained with rabbit antielastin antibody
PR533 (1/100; Elastin Products Company) and mouse anti-FLAG M2 antibody
(1/100; Sigma). Alexa Fluor 546-conjugated anti-rabbit IgG (1/100; Invitrogen)
and Alexa Fluor 488-conjugated anti-mouse IgG (1/100; Invitrogen) were used as
secondary antibodies. Stained cells were mounted with Vectashield with 4,6-
diamino-2-phenylindole (DAPI) (Vector) and examined with a confocal micro-
scope (Carl Zeiss).
RESULTS
Targeted inactivation of the fibulin-4 gene results in perina-
tal lethality. The mouse fibulin-4 gene was inactivated by in-
sertion of a promoterless lacZ and a neomycin-resistant gene
cassette into exon 4 (Fig. 1A). Homologous recombinants were
identified by Southern blot analysis (Fig. 1B). The absence of
fibulin-4 mRNA was confirmed by RT-PCR (Fig. 1C) and
Northern blot analysis (see Fig. 7). We found no adult ho-
mozygous offspring of fibulin-4/ crossings, raising the pos-
sibility that ablation of fibulin-4 causes early lethality. Ge-
notype analysis of offspring at several developmental stages
indicated that the number of wild-type, heterozygous, and
homozygous animals were distributed in a normal Mende-
lian pattern at embryonic stages E11.5 and E18.5 (Table 1).
However, most fibulin-4/ mice died during birth, only
10% survived to P1, and all the homozygous mice died by P2
(Table 1). The frequency of heterozygous animals was about
twice that of the wild type and thus was not affected by the
disruption of one fibulin-4 allele. These results demonstrate
that lack of fibulin-4 causes perinatal lethality in mice.
Severe vascular and lung defects in fibulin-4/ mice. The
gross appearances of wild-type, fibulin-4/, and fibulin-4/
mice at P1 were similar. However, on dissection, fibulin-4/
mice exhibited severe vascular and lung defects. The arteries
were tortuous, with irregularities including narrowing, dilata-
tion, aneurysms, rupture, and resulting hemorrhages. The ab-
normalities were most severe in the aorta (Fig. 2B) and large
arteries but occurred in other arteries as well. In addition, all
live-born fibulin-4/ mice were found to have expanded lungs.
Histological examinations showed markedly enlarged distal
airspaces, similar to those of emphysematous lungs (Fig. 2D).
No obvious difference was observed in other organs. Despite
the severe phenotype exhibited by homozygous animals, het-
erozygous (fibulin-4/) mice are fertile, have a normal life
span, and appear to be indistinguishable from the wild-type
littermates.
The earliest abnormality appears in fibulin-4/ embryos at
E12.5. To determine the onset time of defects in fibulin-4/
mice, we studied different developmental stages of the mice.
The earliest abnormality noted was a uniformly narrowing of
the descending aorta in fibulin-4/ embryos at E12.5 (Fig. 3B).
The outer diameter of the aorta in fibulin-4/ mice was only
FIG. 1. Targeted disruption of the mouse fibulin-4 gene. (A) Tar-
geting strategy. Thick lines represent the homology arms used for
constructing the targeting vector. Numbered solid boxes depict fibu-
lin-4 exons. The external 5 and 3 probes (B) are indicated as two bars
beneath the mutant (mt) locus. wt, wild-type; K, KpnI. (B) Southern
blot analysis of tail genomic DNA from wild-type (/), heterozygous
(/), and homozygous (/) mice. The 15.5-kb wild-type band was
detected by both 5 and 3 probes, the 10-kb mutant band was detected
by the 5 probe, and the 6-kb mutant band was detected by the 3
probe. (C) RT-PCR analysis of mouse RNA. No PCR product was
detected for homozygous mice with either a 3 (1) or 5 (2) primer set,
indicating the absence of fibulin-4 mRNA in these mice. In the positive
control, PCR products were detected for all mice when a 3 or 5
primer set was used for fibulin-3.
TABLE 1. Genotype frequency of offspring from fibulin-4/
mouse breedings
Stage
No. of animals (%) of genotype: Total
no./ / /
E11.5 16 (31) 23 (45) 12 (24) 51
E18.5 18 (21) 45 (52) 23 (27) 86
P1 33 (32) 61 (59) 10 (10) 104
P2 46 (32) 97 (67) 1 (1) 144
P3 53 (31) 118 (69) 0 171
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one-half to two-thirds that of wild-type littermates. Histologi-
cal analyses of cross sections showed that the aortic walls of
fibulin-4/ mice were nearly twice as thick as those of wild-
type mice (Fig. 3D). However, the thickening of the fibulin-
4/ aortic wall did not appear to be the result of subendo-
thelial overproliferation of cells, as the number of cells was
similar in both fibulin-4/ and wild-type aortic wall cross
sections. There were 193  3 cells for the wild type (data
represent means and standard deviations for results with four
mice) and 188  7 cells for the homozygote (four mice) in a
cross section of the aortic wall at a similar level of the thoracic
aorta as shown in Fig. 3C and D. In contrast to the elongated
and spindle-shaped cells in wild-type mice (Fig. 3E), the
fibulin-4/ aortic smooth muscle cells were round and ap-
peared to be less stretched (Fig. 3F). The narrowing and the
cell shape difference of the fibulin-4/ aorta became less
obvious at E13.5 and at older embryonic ages, likely due to
passive expansion of the aorta caused by the dramatic increase
in systemic blood pressure during these stages (22). Aortic
tortuosity and irregularity were noticeable at E15.5 and be-
came more pronounced with age in homozygous animals.
These aorta abnormalities were not observed in fibulin-4/
embryos.
fibulin-4/mice do not form elastic fibers. The vascular and
lung abnormalities of fibulin-4/ mice were suggestive of elastic
fiber defects. The appearance of abnormalities, coincident with
the onset of elastogenesis in mice, suggests that genesis of elastic
fibers may be impaired in fibulin-4/ mice. Thus, we stained
tissue sections from E12.5 to P1 with elastin van Gieson staining,
which specifically stains elastic fibers. In the wild type, the inner-
most elastic lamina of the aorta was identifiable at E13.5 under a
light microscope (Fig. 4A). By E14.5, four elastic laminae could
be distinguished (Fig. 4C). All five elastic laminae were present at
E16.5 or older ages (Fig. 4E and G). In contrast, no continuous
elastic lamina was observed in the fibulin-4/ aorta at any stage
(Fig. 4B, D, F, and H). Instead, irregular elastin aggregates were
visible at E14.5 (Fig. 4D), and more and larger aggregates accu-
mulated with age (Fig. 4F and H). In the lung and skin, elastic
fibers were not distinguishable by light microscopy at any embry-
onic stages. At P1, fine elastic fibers could be observed in lung and
the hypodermal connective tissue of the skin of wild-type mice
(Fig. 5A and C) but not in fibulin-4/ mice (Fig. 5B and D).
Despite this, the skin of fibulin-4/ mice did not show obvious
FIG. 2. Aorta and lung defects in fibulin-4/ mice. (A and B)
Aorta (arrowheads) of fibulin-4/ and fibulin-4/ mice at P1. (C and
D) Hematoxylin and eosin staining of lung sections from mice at P1.
The airspaces are significantly enlarged in fibulin-4/ mice. Scale
bars, 400 m.
FIG. 3. The earliest abnormality in fibulin-4/ mice at E12.5. (A
and B) Aortas of fibulin-4/ and fibulin-4/ embryos at E12.5. (C
to F) Hematoxylin and eosin staining of cross sections of descending
aorta from E12.5 embryos. Note the smaller diameter and thicker wall
of the fibulin-4/ aorta (D). In contrast to the elongated, spindle-
shaped cells (E, arrow) in wild-type mice, aortic wall cells were round
in the fibulin-4/ mice (F, arrow). Scale bars, 50 m (C and D) and
20 m (E and F).
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gross differences at this young age. Elastic fibers of fibulin-4/
mice were similar to those of wild-type littermates. These results
indicate that fibulin-4 is required for general elastogenesis.
Elastin aggregates containing electron dense rod-like fila-
ments in fibulin-4/ mice. To further understand the elastic
fiber defects in fibulin-4/ mice, we examined the aortae of
E14.5 and P1 mice by electron microscopy (Fig. 6). Consistent
with the finding by light microscopy, no intact elastic lamina
was observed in the fibulin-4/ aorta at either E14.5 or P1.
Continuous elastic lamina was present in the wild-type aorta
(Fig. 6A and C), but only irregular elastin aggregates were
found in the fibulin-4/ aorta at both stages (Fig. 6B and D,
arrows). Noticeably, the content of the elastin aggregates ap-
peared to be different from that of normal elastic fibers. In-
stead of an amorphous content, these elastin aggregates con-
tained distinguishable electron-dense substances. Under
higher magnification, dark rod-like filaments with similar sizes
were seen to be evenly distributed in the elastin aggregates
(Fig. 6F). These findings demonstrate that elastin does not
properly assemble without fibulin-4.
Desmosine content is severely reduced in fibulin-4/ mice.
To determine whether mature elastin content is affected in
fibulin-4/ mice, we assessed the level of desmosine, an elas-
tin cross-link-specific amino acid, in the aorta and lungs of
wild-type, heterozygous, and homozygous mutant mice. As
shown in Table 2, elastin cross-linking was nearly absent in
fibulin-4/ mice. There was a 94% decrease in the amount of
desmosine in the aorta and 88% decrease in lungs of fibulin-4/
mice compared with wild-type mice. Interestingly, there was a
near 20% increase in the amount of desmosine in heterozygous
mutants compared with wild-type mice (Table 2), although this
difference was not statistically significant (P 0.05 in a t test). We
did not find any difference in the level of hydroxyproline, an
indicator of collagen content, between wild-type and fibulin-4/
mice (data not shown), indicating that the amount of collagen did
not differ in fibulin-4/ mice.
Tropoelastin and LOX expression is not affected in fibulin-
4/ mice. Elastin cross-linking is catalyzed by LOX family
enzymes. Among the five known members, LOX has been
shown to be necessary for elastic fiber development (20, 31).
To determine whether lack of fibulin-4 causes elastinopathy by
affecting tropoelastin or Lox expression, we examined the
mRNA levels of fibulin-4, tropoelastin, and Lox in wild-type,
heterozygous, and homozygous littermates at P1. As shown in
Fig. 7, while heterozygotes showed reduced fibulin-4 mRNA
levels compared to those in wild-type mice and homozygotes
had no detectable fibulin-4 mRNA, all of them had similar
levels of tropoelastin or Lox expression. Elastin has been
shown to have an antiproliferative effect on vascular smooth
muscle cells, and mice lacking elastin (ELN/) die of vascular
occlusion resulting from subendothelial cell proliferation (27).
The unaffected tropoelastin expression is consistent with the
lack of cell overproliferation and the accumulation of irregular
elastin aggregates in fibulin-4/ mice.
Fibulin-4 interacts with tropoelastin and assembles into
elastic fibers. To investigate possible mechanisms by which
fibulin-4 affects elastogenesis, we assessed the potential for
interaction between fibulin-4 and elastin. Recombinant mouse
fibulin-4 was expressed and purified from stably transfected
293T cell medium (Fig. 8A). A FLAG tag and a His6 tag were
added at the N terminus of fibulin-4 without its signal peptide
to facilitate the purification and characterization of fibulin-4.
FIG. 5. Lack of elastic fibers in the skin and lung of fibulin-4/
mice. (A and B) Elastin van Gieson staining of lung sections from P1
mice. Fine branched elastic fibers (arrowhead) were present in the
wild-type (A) but not fibulin-4/ (B) lung. (C and D) Elastin staining
of skin sections from P1 mice. Elastic fibers were observed in the
hypodermal connective tissue area of the wild-type skin (C, arrow-
head) but not in the fibulin-4/ skin (D). Scale bars, 10 m (A and B)
and 5 m (C and D).
FIG. 4. Lack of elastic lamina in the fibulin-4/ aorta. Elastin
van Gieson staining of cross sections of descending aortae at dif-
ferent developmental stages is shown. The innermost elastic lamina
(arrowheads) was identifiable in the wild-type aorta at E13.5
(A) and became more numerous and thicker at subsequent devel-
oping stages (C, E, and G). Only irregular elastin aggregates (ar-
rows) were observed in the fibulin-4/ aorta (B, D, F, and H). lu,
lumen. Scale bars, 20 m.
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The tagged protein was secreted from a preprotrypsin signal
sequence. Although we found that untagged fibulin-4 was se-
creted efficiently from its native signal peptide, the C-terminal-
tagged fibulin-4 was poorly secreted. It is possible that the
C-terminal domain affects protein folding and is sensitive to
modification. In a solid-phase binding assay, purified tropo-
elastin was used as an immobilized protein substrate, and fibu-
lin-4 was used as a soluble ligand. As shown in Fig. 8B, fibulin-4
bound strongly to tropoelastin in the presence of Ca2 and the
binding was inhibited in the presence of EDTA, suggesting
that calcium is required for the binding and the calcium-bind-
ing epidermal growth factor domains of fibulin-4 may be nec-
essary for this binding. However, it has not been demonstrated
experimentally that fibulin-4 binds calcium. No binding was
observed between fibulin-4 and a control substrate (bovine
serum albumin). These results indicate that fibulin-4 and tropo-
elastin can interact directly.
To assess whether fibulin-4 and tropoelastin interact in so-
lution, we performed a coimmunoprecipitation assay. Human
fibulin-4 cDNA, human tropoelastin cDNA, or both were trans-
FIG. 6. Electron microscopy of elastic laminae in fibulin-4/ mice. (A to D) Descending aorta cross sections from E14.5 (A and B) and P1
(C and D) mice. The wild-type aorta contained continuous elastic lamina (A and C). In contrast, irregular elastin aggregates (arrows) were
randomly distributed in the fibulin-4/ aorta (B and D). Under higher magnification (E and F), the wild-type elastic lamina appeared to be
amorphous (E). But distinct, dark rod-like filaments (F, arrowhead) were evenly distributed in the fibulin-4/ elastin aggregates. SMC, smooth
muscle cell. Scale bars, 400 nm (A to D) and 100 nm (E and F).
TABLE 2. Desmosine in picomoles per milligram of protein
in aorta and lung at P1
Genotype (n)
Desmosine  SD (% of wild type) in:
Aorta Lung
/ (12) 419.05  125.94 (100) 29.7 14.87 (100)
/ (21) 501.86  133.85 (120)a 35.63  9.08 (120)b
/ (6) 25.35  8.69 (6)c 3.15  1.45 (12)c
a P 	 0.09, compared to the wild type by t test.
b P 	 0.23, compared to the wild type by t test.
c P  0.0001, compared to the wild type by t test.
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fected into 293T cells. Tropoelastin was expressed at a very low
level. We could detect tropoelastin in the cell lysate, but it was
difficult to detect it in the culture medium, presumably due to
its self-coacervation and formation of insoluble elastin in the
medium. Fibulin-4 was expressed at a relatively high level and
could be readily detected in both lysate and medium. Thus, we
chose to use transfected cell lysates for the coimmunoprecipi-
tation assay. As shown in Fig. 8C, tropoelastin was immuno-
precipitated from lysates transfected with either tropoelastin
alone (lane 2) or both tropoelastin and fibulin-4 (lane 1) by the
antitropoelastin antibody. It was also coimmunoprecipitated by
an anti-fibulin-4 monoclonal antibody from the lysate cotrans-
fected with tropoelastin and fibulin-4 (lane 3). The coimmu-
noprecipitation did not appear to be due to a nonspecific
association of tropoelastin with the fibulin-4 antibody beads, as
no tropoelastin signal was detected from the immunoprecipi-
tate by the same antibody from the lysate transfected only with
tropoelastin (lane 4). Reciprocally, fibulin-4 was coimmuno-
precipitated by the anti-tropoelastin antibody from the lysate
transfected with both tropoelastin and fibulin-4 (lane 7) but
not from the lysate transfected with fibulin-4 alone (lane 8),
while it was immunoprecipitated by the fibulin-4 antibody from
both lysates (lanes 5 and 6). These results demonstrate that
fibulin-4 binds specifically with tropoelastin.
To further determine whether exogenous fibulin-4 is colo-
calized to elastic fibers, we added FLAG-tagged recombinant
fibulin-4 to cultured human fibroblasts. These cells are capable
of developing a network of elastic fibers in vitro. Double la-
beling of antitropoelastin and anti-FLAG antibodies showed
colocalization of fibulin-4 and elastin (Fig. 9). These data in-
dicate that fibulin-4 assembles into elastic fibers.
DISCUSSION
Elastic fiber formation is thought to involve extrinsic pro-
teins and an intrinsic capacity for elastin coacervation. How
extrinsic proteins cooperate with each other and with elastin
coacervation to form functional elastic fibers is unknown. Over
30 molecules have been reported to associate with elastic fibers
in morphological studies and in vitro assays (23). But many
FIG. 7. Unaffected tropoelastin and lysyl oxidase expression in
fibulin-4/ mice. Northern blot analysis of equal amount of mouse
lung total RNA shows a fibulin-4 mRNA transcript of 1.8 kb detectable
in wild-type (/) and heterozygous (/) but not homozygous
(/) mice (top). The intensity of the signal is reduced in heterozy-
gous mice. The same blot stripped and reblotted with a tropoelastin
probe shows a 3.8-kb tropoelastin transcript with similar intensity in all
the mice (second panel from the top). Probing with a Lox probe
indicates a 6-kb Lox transcript with similar levels in all mice (third
panel). A GAPDH probe was used as a control (bottom).
FIG. 8. Fibulin-4 interacts with tropoelastin. (A) Purified recombinant mouse fibulin-4. A total of 1 g of purified fibulin-4 was used for the
Coomassie blue-stained gel, and 10 ng of the protein was used for the Western blot. An anti-FLAG antibody was used for immunodetection. A
single band with the correct mass for fibulin-4 was detected by both Coomassie blue staining and immunoblotting. (B) Solid-phase binding assay
using recombinant fibulin-4 as a soluble ligand. Note that fibulin-4 binds to tropoelastin in the presence of Ca2 but that the binding is inhibited
in the presence of EDTA. Data were obtained as the results of triplicate experiments, and values shown are means  standard deviations.
(C) Coimmunoprecipitation of fibulin-4 with tropoelastin. Lanes 1 to 4, antitropoelastin blotting of immunoprecipitates from lysates of 293T cells
transfected with both tropoelastin and fibulin-4 (lanes 1 and 3) or tropoelastin alone (lanes 2 and 4). Tropoelastin was detected in the
immunoprecipitate by anti-fibulin-4 (7B9) (lane 3). Lanes 5 to 8, anti-fibulin-4 (11E2) blotting of immunoprecipitates from lysates of 293T cells
transfected with both tropoelastin and fibulin-4 (lanes 5 and 7) or fibulin-4 alone (lanes 6 and 8). Fibulin-4 was detected in the immunoprecipitate
by antitropoelastin (lane 7). IP, immunoprecipitation; TE, tropoelastin; fb4, fibulin-4.
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have been found to have no effect or marginal effects on elastic
fiber formation in vivo. In this study, we demonstrated that
mice lacking fibulin-4 do not form elastic fibers. This is the first
report that lack of a protein other than elastin itself completely
abolishes the formation of elastic fibers in vivo, indicating that
fibulin-4 plays an indispensable role in elastogenesis.
The initial abnormality present in fibulin-4/ mice, arterial
narrowing, is similar to that observed with ELN/ mice (27).
In ELN/ mice, however, the change is caused by subendo-
thelial cell overproliferation due to the lack of elastin, a pro-
cess that eventually obliterates the vascular lumen (27). In
fibulin-4/ mice, tropoelastin mRNA levels are similar to
those in wild-type mice, there is no sign of cell overprolifera-
tion and vascular occlusion, and irregular elastin aggregates
accumulate with age, suggesting that fibulin-4 does not affect
the synthesis of tropoelastin. The formation of functional elas-
tic fibers requires the deposition of tropoelastin at the fiber
assembly site, cross-linking of tropoelastin monomers by lysyl
oxidase family enzymes, and the organization of resulting in-
soluble elastin matrix into mature fibers. Fibulin-4 likely affects
one or more of these processes.
The irregular elastin aggregates observed in fibulin-4/
mice are highly unusual in that they contain electron-dense
rod-like filaments. These filaments are evenly distributed in the
aggregates in fibulin-4/ mice, as if, without fibulin-4, a mol-
ecule(s) associated with tropoelastin is incorporated together
with each tropoelastin monomer into elastin aggregates. Al-
ternatively, the rod-like filament may be a regular elastic
fiber component whose presence is revealed by the absence
of fibulin-4. The morphology of fibulin-4/ elastin aggregates
is similar to that of abnormal elastin aggregates permeated by
proteoglycans in the presence of lysyl oxidase inhibitors (13).
Also, ECM proteoglycans containing sulfated glycosamino-
glycans visualized by a cationic copper phthalocyanin dye,
cupromeronic blue, exhibit morphology very similar to the
rod-like filaments observed in irregular elastin aggregates in
fibulin-4/ mice (48). These observations suggest that the
filaments in fibulin-4/ elastin aggregates may be proteogly-
cans. Glycosaminoglycans containing sulfate groups (chon-
droitin, dermatan, and heparan sulfate) and their associated
proteoglycans have been shown to directly interact with tro-
poelastin and are normal components of elastic fibers (3, 7, 17,
55). Both chondroitin sulfate and heparan sulfate can mediate
tropoelastin’s coacervation (17, 24, 45, 53, 55). Decreased elas-
tin deposition was observed when the matrix was depleted of
sulfated molecules by chlorate treatment of the cells (8, 53).
We also found that fibulin-4 interacts with tropoelastin directly
and assembles into elastic fibers in culture. Thus, fibulin-4 may
play a role in the initial deposition of tropoelastin, such as
scaffolding and facilitating the formation of homogeneous elas-
tin polymers by preventing the association of other molecules
with tropoelastin or coordinating tropoelastin and other elastic
fiber components during elastic fiber assembly. The identity of
the rod-like filaments, the precise roles of proteoglycans in
elastogenesis, and their relationships with fibulin-4 remain to
be determined.
Elastin cross-linking is severely affected in fibulin-4/ mice.
Desmosine was reduced by over 85% in fibulin-4/ mice,
compared to levels in wild-type mice. Interestingly, there was a
near-20% increase in desmosine in fibulin-4/ mice compared
to wild-type mice, although this difference was not statistically
significant with the number of animals we analyzed. It is pos-
sible that there is more cross-linking in heterozygous mutants
than in wild-type mice to compensate for fibulin-4 haploinsuf-
ficiency. Elastin cross-linking is catalyzed by lysyl oxidases, a
family of enzymes that catalyzes the oxidative deamination of
lysine residues in elastin and collagen (21). Five members have
been described so far (12, 30). LOX has been shown to be
necessary for elastic fiber and collagen fiber development (20,
31), and LOX-like 1 (LOXL1) is required in elastic fiber ho-
meostasis (28). Similar to fibulin-4/ mice, Lox/ mice ex-
hibit severe vascular defects and die perinatally (20, 31). The
vascular defects include artery tortuosity, irregularity, and rup-
tured aneurysms with fragmented elastic lamina in the aortic
walls. Desmosine content is decreased by 60%; hydroxyproline,
which represents collagen content, is decreased by 30% in
Lox/ mice (20). The similarities in gross defects between
fibulin-4/ mice and Lox/ mice and loss of desmosine con-
tent in fibulin-4/ mice suggest that lack of fibulin-4 may
affect the function of lysyl oxidase. However, Lox mRNA ex-
pression is similar in wild-type and fibulin-4/ mice, hy-
droxyproline content is not altered in fibulin-4/ mice, and no
unusual elastic fiber content such as rod-like filaments found in
fibulin-4/ mice has been reported with Lox/ mice. Loxl1-
null mice survive to adulthood but do not deposit normal
elastic fibers in the uterine tract postpartum; they develop
FIG. 9. Colocalization of fibulin-4 and elastin. (A to C) Normal human skin fibroblasts were cultured with FLAG-tagged recombinant fibulin-4
protein. (A) Cells stained with antitropoelastin antibody, showing a network structure. (B) Cells stained with anti-FLAG antibody, also showing
a network structure. (C) Superimposed image of panels A and B, with DAPI nuclear staining showing fibulin-4 localization on elastic fibers.
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pelvic prolapse, enlarged airspaces of the lung, loose skin, and
vascular abnormalities. Desmosine content in Loxl1/ mice is
reduced by 30 to 50%, depending on tissues (28). The differ-
ence in elastic fiber defects in fibulin-4/, Lox/, and
Loxl1/ mice suggests that fibulin-4 has different roles in
elastic fiber assembly, even if it also affects the activities of lysyl
oxidases.
Fibulin-4 shares high homology with fibulin-5, with a similar
domain structure and 50% amino acid identity. Fibulin-5-
null mice grow to adulthood but exhibit loose skin, lung air-
space enlargement, and a stiff and tortuous aorta, due to dis-
organized and fragmented elastic fibers (40, 56). It has been
proposed that fibulin-5 may be involved in elastogenesis by
tethering elastic fibers onto cell surface integrins and by affect-
ing cross-linking of elastin through direct binding with LOXL1
(28, 40, 56). Loxl1/ mice exhibit similar but less-severe elas-
tic fiber defects than fibulin-5/ mice. Despite the high ho-
mology between fibulin-4 and -5, the fibulin-4/ phenotype is
not compensated for by fibulin-5. fibulin-4/ mice exhibited
almost complete loss of elastic fibers and perinatal lethality,
suggesting a more essential role of fibulin-4 in elastogenesis
than that of fibulin-5.
With age and some pathological conditions, elastic fibers
exhibit interwoven filaments (41) that are similar to the mor-
phology of elastin aggregates of fibulin-4/ mice. Thus, alter-
ation of the function or structure of fibulin-4 may be a major
mechanism behind aging and elastic fiber-related diseases.
fibulin-4/ mice exhibit the most severe elastinopathy de-
scribed to date. Understanding the role of fibulin-4 is a pre-
requisite for understanding the mechanism responsible for
elastogenesis. In addition to the crucial role in elastogenesis,
fibulin-4 may also have other important functions in cell pro-
liferation and differentiation. Several studies have found that
fibulin-4 stimulates cell growth and is upregulated in tumors
(14, 16, 19). fibulin-4/ mice will also be a valuable model in
further studying these functions.
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